Report Detail

Other Global Cancer (Tumor) Profiling Market Size, Status and Forecast 2020-2026

  • RnM4116624
  • |
  • 06 August, 2020
  • |
  • Global
  • |
  • 95 Pages
  • |
  • QYResearch
  • |
  • Other

Cancer (Tumor) Profiling market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer (Tumor) Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies

Market segment by Type, the product can be split into
Immunoassay
Hybridization
NGS
Mass Spectrometry
Market segment by Application, split into
Clinical
Research

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cancer (Tumor) Profiling Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Immunoassay
    • 1.4.3 Hybridization
    • 1.4.4 NGS
    • 1.4.5 Mass Spectrometry
  • 1.5 Market by Application
    • 1.5.1 Global Cancer (Tumor) Profiling Market Share by Application: 2020 VS 2026
    • 1.5.2 Clinical
    • 1.5.3 Research
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer (Tumor) Profiling Market Perspective (2015-2026)
  • 2.2 Global Cancer (Tumor) Profiling Growth Trends by Regions
    • 2.2.1 Cancer (Tumor) Profiling Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer (Tumor) Profiling Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cancer (Tumor) Profiling Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cancer (Tumor) Profiling Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer (Tumor) Profiling Players by Market Size
    • 3.1.1 Global Top Cancer (Tumor) Profiling Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cancer (Tumor) Profiling Market Concentration Ratio
    • 3.2.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2019
  • 3.3 Cancer (Tumor) Profiling Key Players Head office and Area Served
  • 3.4 Key Players Cancer (Tumor) Profiling Product Solution and Service
  • 3.5 Date of Enter into Cancer (Tumor) Profiling Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Cancer (Tumor) Profiling Market Size by Application (2015-2020)
  • 5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cancer (Tumor) Profiling Market Size (2015-2020)
  • 6.2 Cancer (Tumor) Profiling Key Players in North America (2019-2020)
  • 6.3 North America Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 6.4 North America Cancer (Tumor) Profiling Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cancer (Tumor) Profiling Market Size (2015-2020)
  • 7.2 Cancer (Tumor) Profiling Key Players in Europe (2019-2020)
  • 7.3 Europe Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 7.4 Europe Cancer (Tumor) Profiling Market Size by Application (2015-2020)

8 China

  • 8.1 China Cancer (Tumor) Profiling Market Size (2015-2020)
  • 8.2 Cancer (Tumor) Profiling Key Players in China (2019-2020)
  • 8.3 China Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 8.4 China Cancer (Tumor) Profiling Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cancer (Tumor) Profiling Market Size (2015-2020)
  • 9.2 Cancer (Tumor) Profiling Key Players in Japan (2019-2020)
  • 9.3 Japan Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 9.4 Japan Cancer (Tumor) Profiling Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cancer (Tumor) Profiling Market Size (2015-2020)
  • 10.2 Cancer (Tumor) Profiling Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cancer (Tumor) Profiling Market Size by Application (2015-2020)

11 India

  • 11.1 India Cancer (Tumor) Profiling Market Size (2015-2020)
  • 11.2 Cancer (Tumor) Profiling Key Players in India (2019-2020)
  • 11.3 India Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 11.4 India Cancer (Tumor) Profiling Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cancer (Tumor) Profiling Market Size (2015-2020)
  • 12.2 Cancer (Tumor) Profiling Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cancer (Tumor) Profiling Market Size by Type (2015-2020)
  • 12.4 Central & South America Cancer (Tumor) Profiling Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Illumina
    • 13.1.1 Illumina Company Details
    • 13.1.2 Illumina Business Overview
    • 13.1.3 Illumina Cancer (Tumor) Profiling Introduction
    • 13.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2015-2020))
    • 13.1.5 Illumina Recent Development
  • 13.2 Qiagen
    • 13.2.1 Qiagen Company Details
    • 13.2.2 Qiagen Business Overview
    • 13.2.3 Qiagen Cancer (Tumor) Profiling Introduction
    • 13.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.2.5 Qiagen Recent Development
  • 13.3 Neogenomics Laboratories
    • 13.3.1 Neogenomics Laboratories Company Details
    • 13.3.2 Neogenomics Laboratories Business Overview
    • 13.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
    • 13.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.3.5 Neogenomics Laboratories Recent Development
  • 13.4 HTG Molecular Diagnostics
    • 13.4.1 HTG Molecular Diagnostics Company Details
    • 13.4.2 HTG Molecular Diagnostics Business Overview
    • 13.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
    • 13.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.4.5 HTG Molecular Diagnostics Recent Development
  • 13.5 Genomic Health
    • 13.5.1 Genomic Health Company Details
    • 13.5.2 Genomic Health Business Overview
    • 13.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
    • 13.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.5.5 Genomic Health Recent Development
  • 13.6 Caris Life Sciences
    • 13.6.1 Caris Life Sciences Company Details
    • 13.6.2 Caris Life Sciences Business Overview
    • 13.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
    • 13.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.6.5 Caris Life Sciences Recent Development
  • 13.7 Helomics Corporation
    • 13.7.1 Helomics Corporation Company Details
    • 13.7.2 Helomics Corporation Business Overview
    • 13.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
    • 13.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.7.5 Helomics Corporation Recent Development
  • 13.8 Nanostring Technologies
    • 13.8.1 Nanostring Technologies Company Details
    • 13.8.2 Nanostring Technologies Business Overview
    • 13.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
    • 13.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.8.5 Nanostring Technologies Recent Development
  • 13.9 Oxford Gene Technology
    • 13.9.1 Oxford Gene Technology Company Details
    • 13.9.2 Oxford Gene Technology Business Overview
    • 13.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
    • 13.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.9.5 Oxford Gene Technology Recent Development
  • 13.10 Ribomed Biotechnologies
    • 13.10.1 Ribomed Biotechnologies Company Details
    • 13.10.2 Ribomed Biotechnologies Business Overview
    • 13.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
    • 13.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
    • 13.10.5 Ribomed Biotechnologies Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Cancer (Tumor) Profiling. Industry analysis & Market Report on Cancer (Tumor) Profiling is a syndicated market report, published as Global Cancer (Tumor) Profiling Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Cancer (Tumor) Profiling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report